CD4 and COVID-19: Inactivated virus COVID-19 vaccines, such as CoronaVac and Covaxin (BBV152), generate relatively weak CD4 T-cell responses and a mixture of Th1 and Th2 cells, but Covaxin may be more effective due to substantial Th1 and TFH-cell responses [94].